Labeler · US market

E.R. Squibb & Sons, L.L.C.

E.R. Squibb & Sons, L.L.C. is a US drug labeler with US FDA registrations covering 25 drug concepts (25 currently active) across 71 packages. It is currently the only active US supplier of 20 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes0003

Active drugs25

Registrations49 active / 49

Packages71

Sole supplier of20 drugs

Portfolio25 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Xanomeline And Trospium Chloride capsule, coated pellets	rx	3	9	SUPPLYING
Apixaban tablet, film coated	rx	2	7	SUPPLYING
Triamcinolone Acetonide injection, suspension	rx	3	6	SUPPLYING
Abatacept injection, solution	rx	3	6	SUPPLYING
Dasatinib tablet	rx	6	6	SUPPLYING
Repotrectinib capsule	rx	2	4	SUPPLYING
Nivolumab injection	rx	4	4	SUPPLYING
Apixaban tablet, for suspension	rx	1	3	SUPPLYING
Entecavir tablet, film coated	rx	2	2	SUPPLYING
Elotuzumab injection, powder, lyophilized, for solution	rx	2	2	SUPPLYING
Halcinonide solution	rx	1	2	SUPPLYING
Ipilimumab injection	rx	2	2	SUPPLYING
Aztreonam injection, powder, for solution	rx	2	2	SUPPLYING
Nivolumab And Hyaluronidase-Nvhy injection, solution	rx	2	2	SUPPLYING
Atazanavir capsule, gelatin coated	rx	2	2	SUPPLYING
Xanomeline And Trospium Chloride kit	rx	2	2	SUPPLYING
Deucravacitinib tablet, film coated	rx	1	2	SUPPLYING
Belatacept injection, powder, lyophilized, for solution	rx	1	1	SUPPLYING
Apixaban kit	rx	2	1	SUPPLYING
Atazanavir And Cobicistat tablet	rx	1	1	SUPPLYING
Entecavir solution	rx	1	1	SUPPLYING
Abatacept injection, powder, lyophilized, for solution	rx	1	1	SUPPLYING
Apixaban capsule	rx	1	1	SUPPLYING
Nivolumab And Relatlimab-Rmbw injection	rx	1	1	SUPPLYING
Atazanavir powder	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

+10 more

At a glance

TypeLabeler
Labeler codes0003
Filing names1
Drugs (active)25
Drugs (all time)25
US registrations49
Packages71

Recent events

Shortages, recalls, and registration changes across all filing names.

Nov 3, 2025
RESOLVEDShortage resolved: Atazanavir Sulfate; Cobicistat Tablet (Bristol Myers Squibb Co.)
Nov 3, 2025
SHORTAGEDrug shortage: Atazanavir Sulfate; Cobicistat Tablet (Bristol Myers Squibb Co.)

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.